Neoadjuvant Chemotherapy in Soft Tissue Sarcomas: Latest Evidence and Clinical Implications

Therapeutic Advances in Medical Oncology - United States
doi 10.1177/1758834017705588
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

SAGE Publications

Related search

Chemotherapy in Pediatric-Type Soft-Tissue Sarcomas

Current Oncology
Oncology
2020English

T2 -Based MRI Delta-Radiomics Improve Response Prediction in Soft-Tissue Sarcomas Treated by Neoadjuvant Chemotherapy.

Journal of Magnetic Resonance Imaging
Nuclear MedicineRadiologyImaging
2018English

Feasibility of Chemotherapy in Treatment of Adult Soft Tissue Sarcomas

Orthopedics & Traumatology
2005English

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses After the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas

Clinical Cancer Research
Cancer ResearchOncology
2009English

Pediatric Bone and Soft-Tissue Sarcomas

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2015English

Analysis of Dietary Intake During Consecutive-Day Chemotherapy for Bone and Soft-Tissue Sarcomas

Frontiers in Nutrition
NutritionDieteticsFood ScienceEndocrinologyMetabolismDiabetes
2018English

Diabetes and Bone Health: Latest Evidence and Clinical Implications

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2017English

Notch Signaling in Pediatric Soft Tissue Sarcomas

BMC Medicine
Medicine
2012English

Anticholinergic Medication Use and Dementia: Latest Evidence and Clinical Implications

Therapeutic Advances in Drug Safety
Pharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy